Company Overview and News

 
38 firms record 205 director share purchases worth HK$252m, against 17 firms with 92 disposals worth HK$102m

2017-05-21 scmp
Several combo purchases, with acquisitions by two former directors in Country Garden Holdings and two non-execs at CLP Holdings

 
Global Toys and Games Market 2017-2021

2017-04-05 prnewswire
Toys and games are used for the amusement and entertainment of children. Activity toys such as building sets, dolls, puzzles such as jigsaw puzzles, and card games help children enhance their mental agility and develop coordination and manual skills. The increasing consumer demand for branded toys and games, the growing willingness of parents to spend more on such products, and the rising per capita disposable income are some of the factors leading to an increase in the demand for toys and games globally.

 
Global Animation Collectibles Market 2017-2021

2017-02-24 prnewswire
NEW YORK, Feb. 23, 2017 /PRNewswire/ -- Animation Collectibles Animation collectibles include licensed merchandise as well as animation toys with characters and properties from feature films and television shows. The merchandise industry, many a times, requires merchandise manufacturers to buy licenses from film or TV production houses. Technavio's analysts forecast the global animation collectibles market to grow at a CAGR of 4.

 
The Toy Insider Unveils the Hottest Toys for Holiday 2016 with Hot 20, Top Tech 12 and STEM 10 Lists

2016-09-22 prnewswire
NEW YORK, Sept. 22, 2016 /PRNewswire/ -- The Toy Insider unveiled its expert picks for the best kids' toys and tech in its 11th annual holiday gift guide (http://www.thetoyinsider.com/2016-holiday-gift-guide/) today. The hottest items for 2016 are broken out into three lists: the Hot 20 (the items expected to top kids' wish lists), Top Tech 12 (drones, wearables, robotic pets, and more) and STEM 10 (science, technology, engineering and math toys that make learning fun).

 
Improve Your Returns With These 3 Great Foreign Stocks

2016-09-18 seekingalpha
I am trying to provide good statistical picks. These are stocks that are likely to outperform the market. This is different from most stocks you read about on this site: high conviction picks. Most of these articles underestimate the factor chance, or luck, in the game of investing. Unfortunately this factor is very important in investing. Each time when we are buying or selling a stock we are just rolling a dice.

 
Teenage Mutant Ninja Turtles Talk, Sprint And Blast Their Way Into Action In 2016

2016-02-12 prnewswire
EL SEGUNDO, Calif., Feb. 12, 2016 /PRNewswire/ -- Playmates Toys, the company behind the popular Teenage Mutant...

 
Playmates Toys: Unknown, Undervalued, Misunderstood

2016-01-26 seekingalpha
Playmates Toys has a history of strong profitability.The company has retained the TMNT toy license for over 30 years - they remain the clear choice for toy manu

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...